MINDY2
Ubiquitin carboxyl-terminal hydrolase MINDY-2
Also known as: FAM63B, KIAA1164, MINY2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBR6
- Gene
- MINDY2
- Ensembl
- ENSG00000128923
- Chromosome
- 15
- Canonical length
- 621 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables peptidase activity and polyubiquitin modification-dependent protein binding activity. Predicted to be involved in chromatin remodeling and proteolysis. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
621 residues, UniProt reviewed canonical sequence.
>Q8NBR6|MINDY2
1 MESSPESLQP LEHGVAAGPA SGTGSSQEGL QETRLAAGDG PGVWAAETSG GNGLGAAAAR
61 RSLPDSASPA GSPEVPGPCS SSAGLDLKDS GLESPAAAEA PLRGQYKVTA SPETAVAGVG
121 HELGTAGDAG ARPDLAGTCQ AELTAAGSEE PSSAGGLSSS CSDPSPPGES PSLDSLESFS
181 NLHSFPSSCE FNSEEGAENR VPEEEEGAAV LPGAVPLCKE EEGEETAQVL AASKERFPGQ
241 SVYHIKWIQW KEENTPIITQ NENGPCPLLA ILNVLLLAWK VKLPPMMEII TAEQLMEYLG
301 DYMLDAKPKE ISEIQRLNYE QNMSDAMAIL HKLQTGLDVN VRFTGVRVFE YTPECIVFDL
361 LDIPLYHGWL VDPQIDDIVK AVGNCSYNQL VEKIISCKQS DNSELVSEGF VAEQFLNNTA
421 TQLTYHGLCE LTSTVQEGEL CVFFRNNHFS TMTKYKGQLY LLVTDQGFLT EEKVVWESLH
481 NVDGDGNFCD SEFHLRPPSD PETVYKGQQD QIDQDYLMAL SLQQEQQSQE INWEQIPEGI
541 SDLELAKKLQ EEEDRRASQY YQEQEQAAAA AAAASTQAQQ GQPAQASPSS GRQSGNSERK
601 RKEPREKDKE KEKEKNSCVI LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MINDY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 17 nTPM
- retina: 15 nTPM
- heart muscle: 10 nTPM
- kidney: 9.5 nTPM
- spinal cord: 9 nTPM
- thyroid gland: 9 nTPM
Single-cell type
- early spermatids: 285 nCPM
- papillary tip epithelial cells: 210 nCPM
- extravillous trophoblasts: 204 nCPM
- respiratory basal cells: 192 nCPM
- prostatic club cells: 186 nCPM
- late spermatids: 184 nCPM
Immune cell
- basophil: 2.9 nTPM
- MAIT T-cell: 2 nTPM
- naive B-cell: 1.5 nTPM
- neutrophil: 1.3 nTPM
- non-classical monocyte: 1.3 nTPM
- eosinophil: 1.2 nTPM
Brain region
- cerebellum: 33 nTPM
- hypothalamus: 27 nTPM
- midbrain: 26 nTPM
- thalamus: 26 nTPM
- medulla oblongata: 25 nTPM
- pons: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cysteine-type carboxypeptidase activity
- cysteine-type deubiquitinase activity
- K48-linked deubiquitinase activity
- K48-linked polyubiquitin modification-dependent protein binding
- K6-linked polyubiquitin modification-dependent protein binding
- K63-linked polyubiquitin modification-dependent protein binding
- K11-linked polyubiquitin modification-dependent protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MINDY2 as an antibody target. Whether an autoantibody or antibody against MINDY2 could matter depends on whether native MINDY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MINDY2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MINDY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...